Clinical Study

Effect of Weight Loss, Exercise, or Both on Undercarboxylated Osteocalcin and Insulin Secretion in Frail, Obese Older Adults

Table 1

Baseline characteristics of participants.

Control ()Diet ()Exercise ()Diet-exercise () value

Age (y)69 ± 170 ± 170 ± 170 ± 10.85
Female/male (n)18/917/916/1016/120.89
White, n (%)22 (81)23 (88)21 (81)25 (89)0.78
Height (cm)165.8 ± 1.9169.2 ± 1.9168.1 ± 1.1165.4 ± 1.60.38
Weight (kg)101.0 ± 3.2104.1 ± 2.999.2 ± 3.399.1 ± 3.40.66
Body mass index (kg/m2)37.3 ± 0.937.2 ± 0.936.9 ± 1.137.2 ± 1.00.93
Body composition
 Fat-free mass (kg)57.3 ± 2.261.4 ± 2.557.6 ± 2.757.2 ± 1.90.17
 Fat mass (kg)43.8 ± 1.942.8 ± 1.341.6 ± 1.941.9 ± 2.20.84
 Trunk fat (kg)22.4 ± 1.121.8 ± 0.821.2 ± 0.820.9 ± 0.90.54
Bone turnover and BMD
 CTX (ng/ml)0.407 ± 0.0390.309 ± 0.0240.350 ± 0.0290.320 ± 0.0230.09
 PINP (μg/l)52.2 ± 5.341.5 ± 2.445.2 ± 2.843.1 ± 2.50.14
 WB BMD (g/cm2)1.207 ± 0.0341.252 ± 0.0361.188 ± 0.0341.269 ± 0.0330.30
Physical function
 Knee extension strength (Nm)70.0 ± 5.270.8 ± 4.872.6 ± 5.671.4 ± 4.50.99
 Knee flexion strength (Nm)44.7 ± 3.650.3 ± 3.546.4 ± 3.449.1 ± 2.80.63
 VO2peak (l/min)1.7 ± 0.11.8 ± 0.11.8 ± 0. 11.7 ± 0.10.66
Adipocytokines
 hs-CRP (mg/l)22.4 ± 1.121.8 ± 0.821.2 ± 0.820.9 ± 0.90.72
 sTNF R1 (pg/ml)167.2 ± 7.6155.5 ± 6.9166.6 ± 10.0177.5 ± 9.40.36
 Interleukin 6 (pg/ml)3.1 ± 0.81.8 ± 0.11.7 ± 0.22.6 ± 0.70.15
 Leptin (μg/l)38.1 ± 5.236.7 ± 3.437.5 ± 5.234.1 ± 3.90.92
 Adiponectin (ng/ml)31.9 ± 4.723.3 ± 2.420.8 ± 1.524.4 ± 2.50.06

WB BMD: whole body bone mineral density; CTX: C-terminal telopeptide of type I collagen; PINP: intact N-terminal propeptide of type I procollagen; VO2peak: peak oxygen uptake; hs-CRP: high-sensitivity C-reactive protein; sTNF R1: soluble tumor necrosis factor receptor 1. Values are given as mean ± SE. values as calculated with the use of analyses of variance for quantitative data and chi-square tests for counts.